| 一劑 | 兩劑 | 三劑 | ||||
| BioNTech | 科興 | BioNTech | 科興 | BioNTech | 科興 | |
| 對預防出現症狀的效率 | ||||||
| 20至60歲 | 37.4% | 2.1% | 31.0% | 17.9% | 71.5% | 42.3% |
| 60歲或以上 | 沒有保護力 | 沒有保護力 | 沒有保護力 | 沒有保護力 | 71.6% | 50.7% |
| 對預防重症的效率 | ||||||
| 20至60歲 | 85.0% | 60.9% | 95.2% | 91.7% | 98.5% | 98.5% |
| 60歲或以上 | 65.6% | 40.4% | 89.6% | 72.2% | 98.0% | 97.9% |
| 對預防死亡的效率 | ||||||
| 20至60歲 | 93.7% | 65.4% | 96.4% | 94.0% | 99.4% | 未有足夠結果推斷 |
| 60歲或以上 | 73.0% | 51.2% | 92.3% | 77.4% | 98.1% | 98.3% |
| BioNTech | 科興 | |
| 對預防出現症狀的效率 | ||
| 20至60歲 | 58.6% | 29.7% |
| 60歲或以上 | 63.8% | 57.0% |
| 對預防重症的效率 | ||
| 20至60歲 | 68.3% | 81.8% |
| 60歲或以上 | 80.8% | 92.5% |
| 對預防死亡的效率 | ||
| 20至60歲 | 83.1% | 未有足夠結果推斷 |
| 60歲或以上 | 74.9% | 92.6% |
發表於 
返回列表
